RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
1-Year Return
46.93%
This Quarter Return
+4.73%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$937M
AUM Growth
-$121M
(-11%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-17.66%
Top 10 Holdings %
Top 10 Hldgs %
42.97%
Holding
78
New
17
Increased
11
Reduced
13
Closed
24
Top Buys
| 1 |
Corteva
CTVA
|
$50.3M |
| 2 |
Cameco
CCJ
|
$44.9M |
| 3 |
Bunge Global
BG
|
$39M |
| 4 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
$30.1M |
| 5 |
Valero Energy
VLO
|
$27.3M |
Top Sells
| 1 |
Viatris
VTRS
|
$48.2M |
| 2 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$42.9M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$38.4M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
$37.8M |
| 5 |
Heron Therapeutics
HRTX
|
$36.7M |
Sector Composition
| 1 | Healthcare | 18.57% |
| 2 | Technology | 16.84% |
| 3 | Industrials | 15.57% |
| 4 | Energy | 13.23% |
| 5 | Materials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDR
76
DELISTED
McDermott International
MDR
| – | – |
0
| – | – |
|
|
BHVN
77
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-707,952
| Closed | -$36.4M |
|
78
Akebia Therapeutics
AKBA
$801M
| – | – |
-604,481
| Closed | -$4.95M |
|